{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:30:40Z","timestamp":1715041840540},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,6]]},"DOI":"10.7759\/cureus.59732","type":"journal-article","created":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T13:11:47Z","timestamp":1715001107000},"source":"Crossref","is-referenced-by-count":0,"title":["The Development of IgE Multiple Myeloma Following Treatment for Locally Advanced Prostate Cancer"],"prefix":"10.7759","author":[{"given":"Motoki","family":"Fujita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issei","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsunehito","family":"Kambara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.22585","article-title":"Multiple myeloma and renal failure: mechanisms, diagnosis, and management","volume":"14","author":"Kundu S","year":"2022","unstructured":"Kundu S, Jha SB, Rivera AP, et al.. Multiple myeloma and renal failure: mechanisms, diagnosis, and management. Cureus. 2022, 14:e22585. 10.7759\/cureus.22585","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.08.005","article-title":"Recent global patterns in prostate cancer incidence and mortality rates","volume":"77","author":"Culp MB","year":"2020","unstructured":"Culp MB, Soerjomataram I, Efstathiou JA, Bray F, Jemal A. Recent global patterns in prostate cancer incidence and mortality rates. Eur Urol. 2020, 77:38-52. 10.1016\/j.eururo.2019.08.005","journal-title":"Eur Urol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00137","article-title":"Synchronous bone metastasis from multiple myeloma and prostate adenocarcinoma as initial presentation of coexistent malignancies","volume":"8","author":"Adrianzen Herrera DA","year":"2018","unstructured":"Adrianzen Herrera DA, Goldberg-Stein S, Sankin A, Sarungbam J, Sharma J, Gartrell BA. Synchronous bone metastasis from multiple myeloma and prostate adenocarcinoma as initial presentation of coexistent malignancies. Front Oncol. 2018, 8:137. 10.3389\/fonc.2018.00137","journal-title":"Front Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005815","article-title":"IgE type multiple myeloma exhibits hypermutated phenotype and tumor reactive T cells","volume":"10","author":"Kehl N","year":"2022","unstructured":"Kehl N, Kilian M, Michel J, et al.. IgE type multiple myeloma exhibits hypermutated phenotype and tumor reactive T cells. J Immunother Cancer. 2022, 10:e005815. 10.1136\/jitc-2022-005815","journal-title":"J Immunother Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1994.tb00190.x","article-title":"Renal function in newly diagnosed multiple myeloma - a demographic study of 1353 patients. The Nordic Myeloma Study Group","volume":"53","author":"Knudsen LM","year":"1994","unstructured":"Knudsen LM, Hippe E, Hjorth M, Holmberg E, Westin J. Renal function in newly diagnosed multiple myeloma - a demographic study of 1353 patients. The Nordic Myeloma Study Group. Eur J Haematol. 1994, 53:207-12. 10.1111\/j.1600-0609.1994.tb00190.x","journal-title":"Eur J Haematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2019.08.011","article-title":"Clinical features of neuroendocrine prostate cancer","volume":"121","author":"Conteduca V","year":"2019","unstructured":"Conteduca V, Oromendia C, Eng KW, et al.. Clinical features of neuroendocrine prostate cancer. Eur J Cancer. 2019, 121:7-18. 10.1016\/j.ejca.2019.08.011","journal-title":"Eur J Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/s0046-8177(96)90354-8","article-title":"Absence of serum prostate-specific antigen and loss of tissue immunoreactive prostatic markers in advanced prostatic adenocarcinoma after hormonal therapy: a report of two cases","volume":"27","author":"Mai KT","year":"1996","unstructured":"Mai KT, Commons AS, Perkins DG, Yazdi HM, Collins JP. Absence of serum prostate-specific antigen and loss of tissue immunoreactive prostatic markers in advanced prostatic adenocarcinoma after hormonal therapy: a report of two cases. Hum Pathol. 1996, 27:1377-81. 10.1016\/s0046-8177(96)90354-8","journal-title":"Hum Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.918569","article-title":"Biochemical recurrence in prostate cancer and temporal association to bone metastasis","volume":"20","author":"Mahdy A","year":"2019","unstructured":"Mahdy A, Patil R, Parajuli S. Biochemical recurrence in prostate cancer and temporal association to bone metastasis. Am J Case Rep. 2019, 20:1521-5. 10.12659\/AJCR.918569","journal-title":"Am J Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2003.10.029","article-title":"Is there an association between multiple myeloma and prostate cancer?","volume":"63","author":"Kao J","year":"2004","unstructured":"Kao J, Jani AB, Vijayakumar S. Is there an association between multiple myeloma and prostate cancer?. Med Hypotheses. 2004, 63:226-31. 10.1016\/j.mehy.2003.10.029","journal-title":"Med Hypotheses"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0090-4295(02)02074-5","article-title":"Recurrence of prostate adenocarcinoma presenting with multiple myeloma simulating skeletal metastases of prostate adenocarcinoma","volume":"60","author":"Huang E","year":"2002","unstructured":"Huang E, Teh BS, Saleem A, Butler EB. Recurrence of prostate adenocarcinoma presenting with multiple myeloma simulating skeletal metastases of prostate adenocarcinoma. Urology. 2002, 60:1111. 10.1016\/s0090-4295(02)02074-5","journal-title":"Urology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3109\/10428199909058419","article-title":"IgE multiple myeloma","volume":"32","author":"Macro M","year":"1999","unstructured":"Macro M, Andr\u00e9 I, Comby E, et al.. IgE multiple myeloma. Leuk Lymphoma. 1999, 32:597-603. 10.3109\/10428199909058419","journal-title":"Leuk Lymphoma"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1515\/almed-2021-0087","article-title":"IgE multiple myeloma: detection and follow-up","volume":"3","author":"Nafr\u00eda Jim\u00e9nez B","year":"2022","unstructured":"Nafr\u00eda Jim\u00e9nez B, Oliveros Conejero R. IgE multiple myeloma: detection and follow-up. Adv Lab Med. 2022, 3:79-90. 10.1515\/almed-2021-0087","journal-title":"Adv Lab Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.2086","article-title":"Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002 - Medical Research Council Adult Leukaemia Working Party","volume":"23","author":"Augustson BM","year":"2005","unstructured":"Augustson BM, Begum G, Dunn JA, et al.. Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002 - Medical Research Council Adult Leukaemia Working Party. J Clin Oncol. 2005, 23:9219-26. 10.1200\/JCO.2005.03.2086","journal-title":"J Clin Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s0268-960x(99)90014-0","article-title":"Renal failure and multiple myeloma: pathogenesis and treatment of renal failure and management of underlying myeloma","volume":"2","author":"Clark AD","year":"1999","unstructured":"Clark AD, Shetty A, Soutar R. Renal failure and multiple myeloma: pathogenesis and treatment of renal failure and management of underlying myeloma. Blood Rev. 1999, 2:79-90. 10.1016\/s0268-960x(99)90014-0","journal-title":"Blood Rev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2000.90221.x","article-title":"Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic Myeloma Study Group","volume":"65","author":"Knudsen LM","year":"2000","unstructured":"Knudsen LM, Hjorth M, Hippe E. Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic Myeloma Study Group. Eur J Haematol. 2000, 65:175-81. 10.1034\/j.1600-0609.2000.90221.x","journal-title":"Eur J Haematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/245417-the-development-of-ige-multiple-myeloma-following-treatment-for-locally-advanced-prostate-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T13:11:51Z","timestamp":1715001111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/245417-the-development-of-ige-multiple-myeloma-following-treatment-for-locally-advanced-prostate-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,6]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.59732","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,6]]}}}